The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma-Reference-Cited by-同舟云学术

The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma

Published:2021 Issue:3 Volume:9 Page:765-773
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Li Kesang¹²³⁴⁵,Ye Yingyi⁶²³⁷⁵,Liu Liqin⁶²³⁷⁵,Sha Qian⁶⁸⁹⁵,Wang Xiaolu⁶²³⁷⁵,Jiao Ting⁶²³⁷⁵,Zhang Li⁶²³⁷⁵,Wang Jinyan⁶²³⁷⁵^ORCID

Affiliation:

1. Department of Hematology and Oncology

2. Hwa Mei Hospital

3. University of Chinese Academy of Sciences

4. Ningbo 315000

5. China

6. Department of Dermatology

7. Ningbo

8. Maternity & Child Health Hospital

9. Yuyao

Abstract

The response rate to PD-1/PD-L1 immune checkpoint inhibition (ICI) therapy in melanoma remains low due to the immunosuppressive tumor microenvironment.

Funder

Natural Science Foundation of Ningbo

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM00870B

Reference27 articles.

1. N. H. Matthews , W.-Q.Li , A. A.Qureshi , M. A.Weinstock and E.Cho , in Cutaneous melanoma: etiology and therapy [Internet] , Codon Publications , 2017

2. Lessons from Cancer Immunoediting in Cutaneous Melanoma

3. Hard Times for Oncogenic BRAF-Expressing Melanoma Cells

4. Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

5. Cancer immunotherapy using checkpoint blockade

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy;Materials Today;2024-09

2. Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth;International Journal of Nanomedicine;2024-08

3. Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy;2024-05-08

4. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy;Acta Biomaterialia;2024-03

5. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy;Biomarker Research;2024-01-07